What we do—

Changing the world

UCLB is the commercialisation company of UCL and its partner NHS Trusts. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.

Latest news—

Echopoint raises £2.8m to address the ‘grey zone’ of heart disease treatment

Echopoint Medical Ltd, a spinout company from UCL, has raised £2.8m to develop optical sensing technology to help heart disease patients in a grey zone where the need for treatment is unclear.

Featured Technology—

Novel method of analysis of stroke data

Stroke is the leading cause of adult disability in the UK at an estimated cost of £7 billion a year. UCL has developed a system for predicting clinical outcomes so as to provide advance information on the optimum clinical management of each patient.
Spotlight—

How does Portico Ventures support non-patentable and fast-to-deploy technologies?

As Portico Ventures is well under way at UCL, we catch up with Programme Manager Denisa Naidin on how UCLB’s work is helping to speed up the route to commercialisation for Computer Science innovations at UCL.

Featured Technology—

SnakeGrid

SnakeGrid is a way of developing low-distortion coordinate systems for large engineering projects.

Latest news and highlights

Echopoint raises £2.8m to address the ‘grey zone’ of heart disease treatment

/ UCLB News
Echopoint Medical Ltd, a spinout company from UCL, has raised £2.8m to develop optical sensing technology to help heart disease ...

UCLB spinout Endomag makes The Sunday Times Tech Track 100

/ UCLB News
Congratulations to medical device spinout Endomag who has been named in The Sunday Times Tech Track 100 list. The list ...

Four UCLB spinout companies are named finalists in the European Lifestars Awards

/ UCLB News
We are delighted to announce that four UCLB spinout companies have been named finalists for the 2019 European Lifestars Awards ...

Achillies Thereapeutics raises £100 million in oversubscribed series B financing

/ UCLB News
Achilles Therapeutics, a biopharmaceutical company launched in 2016, based on work led by Professor Charles Swanton of UCL and the ...

FIND THE RIGHT MATCH

Whether you’re an academic or looking for technologies, find your UCLB contact here.

 

Commercialising technology since 1993

0
Active spinouts
0
Active licences in 2018
0
Drug discoveries
0
New patent applications